These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 701847)

  • 1. The epidermolytic toxin of Staphylococcus aureus: its failure to bind to cells and its detection in blister fluids of patients with bullous impetigo.
    Baker DH; Dimond RL; Wuepper KD
    J Invest Dermatol; 1978 Oct; 71(4):274-5. PubMed ID: 701847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo.
    Durupt F; Mayor L; Bes M; Reverdy ME; Vandenesch F; Thomas L; Etienne J
    Br J Dermatol; 2007 Dec; 157(6):1161-7. PubMed ID: 17916211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causative agent of impetigo: staphylococcal exfoliative toxin and regulation of the toxin production in Staphylococcus aureus].
    Sakurai S
    Nihon Saikingaku Zasshi; 1996 Aug; 51(3):813-22. PubMed ID: 8840812
    [No Abstract]   [Full Text] [Related]  

  • 4. Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation.
    Nishifuji K; Shimizu A; Ishiko A; Iwasaki T; Amagai M
    J Dermatol Sci; 2010 Sep; 59(3):184-91. PubMed ID: 20728315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolytic toxin from Staphylococcus aureus binds to filaggrins.
    Smith TP; Bailey CJ
    FEBS Lett; 1986 Jan; 194(2):309-12. PubMed ID: 2416597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome.
    Hanakawa Y; Schechter NM; Lin C; Garza L; Li H; Yamaguchi T; Fudaba Y; Nishifuji K; Sugai M; Amagai M; Stanley JR
    J Clin Invest; 2002 Jul; 110(1):53-60. PubMed ID: 12093888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
    Nishifuji K; Sugai M; Amagai M
    J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical syndromes caused by staphylococcal epidermolytic toxin.
    Edlich RF; Horowitz JH; Nichter LS; Silloway KA; Morgan RF
    Compr Ther; 1985 Apr; 11(4):45-8. PubMed ID: 3159536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of clinical S. aureus-isolates for the production of exfoliative toxin. A methodological study.
    Elsner P; Hartmann AA; Lenz W; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):216-20. PubMed ID: 3936308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA; Al-Rubiay KK; Affat AM
    East Mediterr Health J; 2001; 7(1-2):121-7. PubMed ID: 12596961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1.
    Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR
    J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of staphylococcal bullous impetigo in a maternity ward linked to an asymptomatic healthcare worker.
    Occelli P; Blanie M; Sanchez R; Vigier D; Dauwalder O; Darwiche A; Provenzano B; Dumartin C; Parneix P; Venier AG
    J Hosp Infect; 2007 Nov; 67(3):264-70. PubMed ID: 17945394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The staphylococcal scalded skin syndrome in historical perspective: emergence of dermopathic strains of Staphylococcus aureus and discovery of the epidermolytic toxin. A review of events up to 1970.
    Lyell A
    J Am Acad Dermatol; 1983 Aug; 9(2):285-94. PubMed ID: 6350386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.
    Gravet A; Couppié P; Meunier O; Clyti E; Moreau B; Pradinaud R; Monteil H; Prévost G
    J Clin Microbiol; 2001 Dec; 39(12):4349-56. PubMed ID: 11724844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
    Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
    Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
    Kanzaki H; Ueda M; Morishita Y; Akiyama H; Arata J; Kanzaki S
    Dermatology; 1997; 195(1):6-9. PubMed ID: 9267729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns.
    Capoluongo E; Giglio A; Belardi M; Leonetti F; Frasca A; Giannetti A; Ameglio F
    New Microbiol; 2000 Jan; 23(1):21-7. PubMed ID: 10946402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two highly divergent lineages of exfoliative toxin B-encoding plasmids revealed in impetigo strains of Staphylococcus aureus.
    Botka T; Růžičková V; Svobodová K; Pantůček R; Petráš P; Čejková D; Doškař J
    Int J Med Microbiol; 2017 Sep; 307(6):291-296. PubMed ID: 28579477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.